Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
63,573.52 +1,804.26 (+2.92%) CMC Crypto 200
1,359.39 +82.41 (+6.45%)
China Pharma Holdings, Inc. (CPHI)
NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 03:59PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 5.11M |
| Enterprise value | 8.32M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.17 |
| Price/book (mrq) | 0.69 |
| Enterprise value/revenue | 1.19 |
| Enterprise value/EBITDA | 986.60 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.91 |
| 52-week change 3 | -83.78% |
| S&P500 52-week change 3 | 22.38% |
| 52-week high 3 | 2.2000 |
| 52-week low 3 | 0.2700 |
| 50-day moving average 3 | 0.3572 |
| 200-day moving average 3 | 0.6383 |
Share statistics
| Avg vol (3-month) 3 | 427.47k |
| Avg vol (10-day) 3 | 302.37k |
| Shares outstanding 5 | 14.82M |
| Implied shares outstanding 6 | 10.61M |
| Float 8 | 5.6M |
| % held by insiders 1 | 66.63% |
| % held by institutions 1 | 0.83% |
| Shares short (15 Feb 2024) 4 | 93.6k |
| Short ratio (15 Feb 2024) 4 | 0.22 |
| Short % of float (15 Feb 2024) 4 | 1.22% |
| Short % of shares outstanding (15 Feb 2024) 4 | 0.88% |
| Shares short (prior month 12 Jan 2024) 4 | 10.12k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:5 |
| Last split date 3 | 06 Mar 2024 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -43.91% |
| Operating margin (ttm) | -55.10% |
Management effectiveness
| Return on assets (ttm) | -10.04% |
| Return on equity (ttm) | -52.43% |
Income statement
| Revenue (ttm) | 7.01M |
| Revenue per share (ttm) | 2.07 |
| Quarterly revenue growth (yoy) | -26.40% |
| Gross profit (ttm) | N/A |
| EBITDA | 1.83k |
| Net income avi to common (ttm) | -3.08M |
| Diluted EPS (ttm) | -0.9100 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 1.42M |
| Total cash per share (mrq) | 0.1 |
| Total debt (mrq) | 4.63M |
| Total debt/equity (mrq) | 62.16% |
| Current ratio (mrq) | 0.88 |
| Book value per share (mrq) | 0.70 |
Cash flow statement
| Operating cash flow (ttm) | -699.69k |
| Levered free cash flow (ttm) | -168.57k |
© 2024 Yahoo. All rights reserved.